BETA BIONICS INC (BBNX) Fundamental Analysis & Valuation

NASDAQ:BBNX • US08659B1026

Current stock price

10.39 USD
+0.28 (+2.77%)
At close:
10.1736 USD
-0.22 (-2.08%)
After Hours:

This BBNX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BBNX Profitability Analysis

1.1 Basic Checks

  • BBNX had negative earnings in the past year.
  • BBNX had a negative operating cash flow in the past year.
BBNX Yearly Net Income VS EBIT VS OCF VS FCFBBNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -22.27%, BBNX perfoms like the industry average, outperforming 48.91% of the companies in the same industry.
  • BBNX's Return On Equity of -25.45% is in line compared to the rest of the industry. BBNX outperforms 57.07% of its industry peers.
Industry RankSector Rank
ROA -22.27%
ROE -25.45%
ROIC N/A
ROA(3y)-32.98%
ROA(5y)N/A
ROE(3y)-57.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BBNX Yearly ROA, ROE, ROICBBNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • BBNX has a Gross Margin (55.40%) which is comparable to the rest of the industry.
  • The Profit Margin and Operating Margin are not available for BBNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BBNX Yearly Profit, Operating, Gross MarginsBBNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. BBNX Health Analysis

2.1 Basic Checks

  • BBNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BBNX has more shares outstanding than it did 1 year ago.
  • BBNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BBNX Yearly Shares OutstandingBBNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M
BBNX Yearly Total Debt VS Total AssetsBBNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • BBNX has an Altman-Z score of 5.42. This indicates that BBNX is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.42, BBNX belongs to the best of the industry, outperforming 82.07% of the companies in the same industry.
  • There is no outstanding debt for BBNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.42
ROIC/WACCN/A
WACC10.04%
BBNX Yearly LT Debt VS Equity VS FCFBBNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 8.66 indicates that BBNX has no problem at all paying its short term obligations.
  • BBNX's Current ratio of 8.66 is amongst the best of the industry. BBNX outperforms 90.22% of its industry peers.
  • A Quick Ratio of 7.96 indicates that BBNX has no problem at all paying its short term obligations.
  • BBNX's Quick ratio of 7.96 is amongst the best of the industry. BBNX outperforms 89.67% of its industry peers.
Industry RankSector Rank
Current Ratio 8.66
Quick Ratio 7.96
BBNX Yearly Current Assets VS Current LiabilitesBBNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BBNX Growth Analysis

3.1 Past

  • The earnings per share for BBNX have decreased strongly by -41.37% in the last year.
  • The Revenue has grown by 53.94% in the past year. This is a very strong growth!
  • BBNX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 724.29% yearly.
EPS 1Y (TTM)-41.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.34%
Revenue 1Y (TTM)53.94%
Revenue growth 3Y724.29%
Revenue growth 5YN/A
Sales Q2Q%57.15%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.09% on average over the next years.
  • BBNX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.58% yearly.
EPS Next Y-0.29%
EPS Next 2Y-0.37%
EPS Next 3Y9.49%
EPS Next 5Y4.09%
Revenue Next Year34.76%
Revenue Next 2Y34.62%
Revenue Next 3Y36.48%
Revenue Next 5Y35.58%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BBNX Yearly Revenue VS EstimatesBBNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
BBNX Yearly EPS VS EstimatesBBNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. BBNX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BBNX. In the last year negative earnings were reported.
  • Also next year BBNX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BBNX Price Earnings VS Forward Price EarningsBBNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BBNX Per share dataBBNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.37%
EPS Next 3Y9.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BBNX Dividend Analysis

5.1 Amount

  • BBNX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BBNX Fundamentals: All Metrics, Ratios and Statistics

BETA BIONICS INC

NASDAQ:BBNX (3/13/2026, 8:11:07 PM)

After market: 10.1736 -0.22 (-2.08%)

10.39

+0.28 (+2.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners108.24%
Inst Owner Change-0.65%
Ins Owners0.65%
Ins Owner Change15.6%
Market Cap461.11M
Revenue(TTM)100.25M
Net Income(TTM)-73.20M
Analysts82.35
Price Target23.83 (129.36%)
Short Float %13.24%
Short Ratio4.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.48%
Min EPS beat(2)25.39%
Max EPS beat(2)31.57%
EPS beat(4)3
Avg EPS beat(4)-4.93%
Min EPS beat(4)-91.55%
Max EPS beat(4)31.57%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.79%
Min Revenue beat(2)4.13%
Max Revenue beat(2)11.46%
Revenue beat(4)4
Avg Revenue beat(4)8.93%
Min Revenue beat(4)4.13%
Max Revenue beat(4)15.74%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20.43%
PT rev (3m)-25.36%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)-0.3%
EPS NY rev (1m)-7.27%
EPS NY rev (3m)-6.15%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.36%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.6
P/FCF N/A
P/OCF N/A
P/B 1.6
P/tB 1.6
EV/EBITDA N/A
EPS(TTM)-1.94
EYN/A
EPS(NY)-1.95
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-1.15
OCFYN/A
SpS2.26
BVpS6.48
TBVpS6.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.27%
ROE -25.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.4%
FCFM N/A
ROA(3y)-32.98%
ROA(5y)N/A
ROE(3y)-57.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 336.75%
Cap/Sales 5.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.66
Quick Ratio 7.96
Altman-Z 5.42
F-Score5
WACC10.04%
ROIC/WACCN/A
Cap/Depr(3y)221.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.62%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.34%
EPS Next Y-0.29%
EPS Next 2Y-0.37%
EPS Next 3Y9.49%
EPS Next 5Y4.09%
Revenue 1Y (TTM)53.94%
Revenue growth 3Y724.29%
Revenue growth 5YN/A
Sales Q2Q%57.15%
Revenue Next Year34.76%
Revenue Next 2Y34.62%
Revenue Next 3Y36.48%
Revenue Next 5Y35.58%
EBIT growth 1Y-58.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.78%
EBIT Next 3Y13.38%
EBIT Next 5Y13.25%
FCF growth 1Y-8.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.49%
OCF growth 3YN/A
OCF growth 5YN/A

BETA BIONICS INC / BBNX Fundamental Analysis FAQ

What is the fundamental rating for BBNX stock?

ChartMill assigns a fundamental rating of 4 / 10 to BBNX.


What is the valuation status of BETA BIONICS INC (BBNX) stock?

ChartMill assigns a valuation rating of 0 / 10 to BETA BIONICS INC (BBNX). This can be considered as Overvalued.


What is the profitability of BBNX stock?

BETA BIONICS INC (BBNX) has a profitability rating of 1 / 10.


What is the expected EPS growth for BETA BIONICS INC (BBNX) stock?

The Earnings per Share (EPS) of BETA BIONICS INC (BBNX) is expected to decline by -0.29% in the next year.